Home » Newsletters » BioWorld Science

BioWorld Science

May 17, 2017

View Archived Issues

Thermo Fisher Scientific to acquire Patheon

Nevis Capital assumes ASC Biosciences' name and business plan

Boehringer Ingelheim enters partnership with Peking University

Regen BioPharma gives update on NR2F6 program

Dual LXRA/GPBAR1 agonist BAR-130 shows promise for metabolic disorders

Phase II study of mazindol in ADHD meets endpoints

TPVdelta66R/mIL-2 as a novel immunovirotherapy for melanoma

FDA grants priority review to copanlisib NDA for relapsed or refractory follicular lymphoma

Tella Pharma's TLP0-001 studied in Japanese trial for treatment of pancreatic cancer

Astellas completes Ogeda acquisition

Mitsubishi Tanabe Pharma presents CYP11B2 inhibitors

Latvian Institute of Organic Synthesis patents malarial aspartic protease inhibitors

FunPep signs joint research agreement to develop antiviral drug with Fujifilm

Beactica enters glioblastoma research collaboration

Kite initiates phase I study of KITE-718 in advanced cancers

Aska Pharmaceutical identifies prostaglandin E synthase inhibitors

FDA awards fast track designation to Sangamo Therapeutics' SB-525

Roche discovers cyclic peptides for treating bacterial infections

Takeda announces further details of partnership with Bushu Pharmaceuticals

Gan & Lee Pharmaceuticals divulges CDK4/CCND3 and CDK6/CCND3 inhibitors

CANbridge Life Sciences and Amoy to develop companion diagnostic for CAN-008

Newron expands enrollment to include younger children in STARS study of sarizotan for Rett syndrome

Roche identifies EAAT3 inhibitors

Quethera designs rAAV2 vector expressing TrkB and mBDNF for glaucoma

Catalent to support development of Therachon's TA-46 for achondroplasia

Merck & Co. discovers mutant isocitrate dehydrogenase inhibitors

X-Chem establishes drug discovery collaboration with Vertex

RCIGM and Alexion enter partnership to accelerate diagnosis of rare genetic disorders in newborns

Scientists create model of inflammation-sensitized neonatal encephalopathy

AAVrh.10-mNpc2-HA, a new gene therapy for treating Niemann-Pick type C2

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.